Product Introduction:
Vocarb MF 0.3/500 Mg Tablet combines Voglibose and Metformin to manage blood sugar levels in patients with type 2 diabetes. Voglibose slows carbohydrate absorption, while Metformin decreases glucose production in the liver and improves insulin sensitivity.
Uses:
-
Treatment and management of type 2 diabetes mellitus
-
Helps reduce post-meal blood sugar spikes
-
Supports overall glycemic control
Benefit:
-
Controls fasting and postprandial blood glucose levels
-
Helps delay glucose absorption from the intestines
-
Enhances insulin sensitivity and reduces hepatic glucose production
-
Generally well tolerated with fewer side effects
Composition:
-
Voglibose – 0.3 mg
-
Metformin Hydrochloride – 500 mg
Side Effect:
-
Gastrointestinal discomfort such as nausea, diarrhea, or abdominal pain
-
Rare instances of hypoglycemia
-
Possible allergic reactions
-
Metallic taste in mouth
Safety Advice:
-
Take with meals to minimize gastrointestinal side effects
-
Regularly monitor blood glucose levels
-
Inform your doctor if you have kidney or liver conditions
-
Avoid alcohol during treatment
-
Use under medical supervision, especially if pregnant or breastfeeding
